Roche's Columvi combo gains EC approval for DLBCL - Pharmaceutical Technology

Retrieved on: 2025-04-14 15:40:24

Tags for this article:

Click the tags to see associated articles and topics

Roche's Columvi combo gains EC approval for DLBCL - Pharmaceutical Technology. View article details on hiswai:

Excerpt

Roche has secured approval from the EC for Columvi plus GemOx combo to treat adults with R/R diffuse large B-cell lymphoma (DLBCL).

Article found on: www.pharmaceutical-technology.com